28 | Monoclonal AntibodiesIBA
09/2020
-
01/2002 |
20 | N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA
01/2022
-
01/2002 |
14 | Proteins (Proteins, Gene)FDA Link
01/2022
-
04/2006 |
13 | ErbB Receptors (EGF Receptor)IBA
01/2019
-
01/2002 |
10 | Trastuzumab (Herceptin)FDA Link
10/2019
-
11/2003 |
9 | Single-Domain AntibodiesIBA
05/2022
-
01/2013 |
9 | AntigensIBA
01/2022
-
09/2004 |
9 | Peptides (Polypeptides)IBA
01/2022
-
05/2003 |
9 | Radioisotopes (Radionuclides)IBA
03/2021
-
01/2008 |
7 | epidermal growth factor receptor VIIIIBA
04/2016
-
01/2002 |
7 | 3-Iodobenzylguanidine (Iobenguane)IBA
08/2015
-
04/2004 |
7 | 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA
01/2012
-
03/2003 |
6 | RadiopharmaceuticalsIBA
01/2022
-
08/2004 |
6 | Pharmaceutical PreparationsIBA
11/2017
-
01/2012 |
5 | AntibodiesIBA
01/2022
-
08/2010 |
5 | Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
08/2015
-
11/2005 |
5 | TenascinIBA
05/2007
-
11/2002 |
4 | EnzymesIBA
07/2018
-
11/2009 |
3 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2018
-
08/2016 |
3 | Immunotoxins (Immunotoxin)IBA
04/2016
-
06/2008 |
3 | Therapeutic UsesIBA
08/2013
-
08/2009 |
3 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2010
-
05/2003 |
3 | Octreotide (Sandostatin)FDA LinkGeneric
11/2007
-
05/2003 |
2 | Biomarkers (Surrogate Marker)IBA
10/2020
-
08/2013 |
2 | GoldIBA
07/2019
-
01/2015 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
12/2018
-
01/2017 |
2 | EpitopesIBA
12/2017
-
08/2010 |
2 | Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2017
-
10/2011 |
2 | Folic Acid (Vitamin M)FDA LinkGeneric
01/2017
-
01/2015 |
2 | HydrogelsIBA
04/2016
-
07/2012 |
2 | Iodine-125IBA
02/2016
-
01/2006 |
2 | Epidermal Growth Factor (EGF)IBA
01/2012
-
01/2012 |
2 | Alkylating AgentsIBA
01/2011
-
04/2006 |
2 | DNA alkyltransferaseIBA
01/2011
-
04/2006 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2010
-
01/2010 |
2 | Single-Chain AntibodiesIBA
08/2010
-
01/2006 |
2 | Elastin-Like PolypeptidesIBA
05/2010
-
11/2006 |
2 | Glucose (Dextrose)FDA LinkGeneric
01/2010
-
05/2003 |
2 | somatostatin receptor 2IBA
12/2009
-
05/2003 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
11/2007
-
12/2004 |
2 | N-acetyltalosaminuronic acid (NAT)IBA
06/2006
-
11/2005 |
2 | sodium-iodide symporter (sodium iodide symporter)IBA
11/2003
-
10/2002 |
1 | peptide IIBA
01/2022 |
1 | RG7388IBA
10/2021 |
1 | 6- methoxy- 1- (naphthalen- 1- yl)- 9H- pyrido(3,4- b)indoleIBA
04/2021 |
1 | Tumor Suppressor Protein p53IBA
04/2021 |
1 | LigandsIBA
03/2021 |
1 | IsotopesIBA
01/2020 |
1 | 1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2020 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 |
1 | Radiation-Sensitizing AgentsIBA
01/2020 |
1 | human ERBB2 proteinIBA
10/2019 |
1 | Alkaline PhosphataseIBA
01/2019 |
1 | Radium-223IBA
01/2019 |
1 | Fluorine-18IBA
01/2019 |
1 | AGI-5198IBA
01/2018 |
1 | pertuzumabIBA
12/2017 |
1 | Essential Amino AcidsIBA
01/2017 |
1 | MelanocortinsIBA
01/2017 |
1 | Leucine (L-Leucine)FDA Link
01/2017 |
1 | LuciferasesIBA
10/2016 |
1 | Urea (Carbamide)FDA LinkGeneric
10/2016 |
1 | alpha-hydroxyglutarateIBA
08/2016 |
1 | SulfonamidesIBA
08/2016 |
1 | TitaniumIBA
04/2016 |
1 | D2C7-(scdsFv)-PE38KDELIBA
04/2016 |
1 | Antineoplastic Agents (Antineoplastics)IBA
02/2016 |
1 | Growth Factor ReceptorsIBA
01/2016 |
1 | Hormones (Hormone)IBA
10/2014 |
1 | AndrogensIBA
10/2014 |